Telangiectasia Clinical Trials

Find Telangiectasia Clinical Trials Near You

Comparative Study Between Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique

Status: Recruiting
Location: See location...
Intervention Type: Device, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to compare the efficacy (in terms of vein clearance) and safety of Nd:YAG laser combined with injection sclerotherapy versus diode laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias using the Cryo-Laser and Cryo-Sclerotherapy (CLaCS) technique.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:

• Patients aged 18-60 years.

• Both sexes.

• Presence of reticular veins and/or telangiectasias (CEAP classification C1).

• Fitzpatrick skin types II-V.

• Patients seeking cosmetic treatment.

Locations
Other Locations
Egypt
Ain Shams University
RECRUITING
Cairo
Contact Information
Primary
Mohamed A Hagag, MD
hagagmohamed@med.asu.edu.eg
00201126560324
Time Frame
Start Date: 2026-06-01
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 80
Treatments
Experimental: Group A (Nd:YAG Group):
Patients will receive Nd:YAG laser (1064 nm) + injection sclerotherapy (CLaCS).
Experimental: Group B (Diode Group)
Patients will receive Diode laser (980 nm) + injection sclerotherapy (CLaCS).
Related Therapeutic Areas
Sponsors
Leads: Ain Shams University

This content was sourced from clinicaltrials.gov